Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: quidditch who wrote (408)	2/14/2002 12:42:38 AM
From: scaram(o)uche	Read Replies (3) \| Respond to of 724

>> wish I'd bought more, and if it pulls back, I will. << IMO, this is like a guy selling you a fifty for $10. Margin was 41%. Annualized forward, the quarter came in at 69M. That's a cool 29M for a suitor to look at for a single year, given a company with a capitalization of 44M. Can you imagine how Fisher drools when they see that? And DGI just (1) filed the mother of all patent applications with Novo, (2) signed the second deal with Novo, retaining rights to the IGF-1 agonists, and (3) described a new cancer target. Why would anyone sane expect it to "pull back"? Just because it always does? :-)